Actress Tamannaah’s pledge to help Devika ‘Fightagainstcancer’ with Tring Mumbai (Maharashtra) [India], February 19 (ANI/NewsVoir): With a call for the generous hearts to step ahead and contribute, Tamannaah has associated with Tring’s Icons for Change initiative to support a cause that is extremely close to her heart. The actress went live to garner donations for […]

Novel Additions Require Nuanced Treatment Selection in Relapsed/Refractory Myeloma Knowledge of prior therapies a patient has received, adequate prophylactic treatment, and consistent monitoring for unique toxicities is necessary to ensure patients are able to derive optimal benefit from novel options that have explored in relapsed/refractory myeloma therapy, according to Parameswaran Hari, MD, MRCP. “My approach […]

Octapharma: New Consensus Recommendations on Treatment of Secondary Antibody Deficiency … LACHEN, Switzerland–(BUSINESS WIRE)–New expert consensus guidelines on the use of immunoglobulin replacement therapy (IgRT) in patients with haematological malignancy and secondary antibody deficiencies (SAD) were recently published in the European Journal of Haematology. The publication, sponsored by Octapharma, marks the first pan-European consensus guidance […]

Benefits and problems of allogeneic stem cell transplantation as multiple myeloma treatment Prof Kröger talks to ecancertv at ICMM 2016 about the standard treatment of multiple myeloma in younger patients. In particular, he highlights both the benefits and complications associated with allogeneic stem cell transplants.

Revlimid Drug Market Strategies, Industry Verticals Forecast to 2027 BY Bristol-Myers Squibb … Revlimid, also known as Lenalidomide, is a medication used to treat multiple myeloma and myelodysplastic syndromes. For multiple myeloma, it is used after at least one other treatment and generally together with dexamethasone. It works by slowing or stopping cancer cells’ growth […]

Waldenström Macroglobulinemia 2020 Year-End Update: Diagnosis and Treatment Considerations A year-end update1 on Waldenström macroglobulinemia (WM), a distinct entity of lymphoplasmacytic lymphoma presenting with monoclonal pleomorphic immunoglobulin M (IgM) proteins,2 has been published in the American Journal of Hematology. The incidence of WM has not changed over the past 50 years, persisting at a relatively […]